Perrigo Company plc — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Ireland
Last price 15.87 USD (Nov 2, 2026, 11:39 AM EST) · Market cap 2.20B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Details
| Name | Perrigo Company plc |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 8100 |
| Founded | 1887 |
| Ipo Date | 1991-12-16 |
| Ceo | Albert Manzone |
| Country | Ireland |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | IE00BGH1M568 |
| Cusip | G97822103 |
| Cik | 0001585364 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Albert Ange Manzone | Interim President, Interim Chief Executive Officer and Director |
| Eduardo Guarita Bezerra | Executive Vice President and Chief Financial Officer |
| Abbie Lennox | Executive Vice President and Chief Scientific Officer |
| Charles Atkinson | Executive Vice President, General Counsel and Secretary |
| Roberto Khoury | Executive Vice President and Chief Commercial Officer |
| Eric S. Jacobson | Vice President of Global Investor Relations |
| Robert Willis | Chief Human Resources Officer and Executive Vice President |
| Dr. David Ball | Executive Vice President and Chief Brand and Digital Officer |
| Matthew Winterman | Executive Vice President of Product Supply, Operations Strategy and Transformation Officer |
| Sonia Hollies | Senior Vice President and Treasurer |
Contact
| Address | The Sharp Building, Hogan Place, Dublin, D02 TY74, Ireland |
| Phone | 353 1 709 4000 |
| Website | https://www.perrigo.com |